{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:30:56Z","timestamp":1792765856833,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12660-9","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:55:28Z","timestamp":1769104528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical and microbiological characteristics of polymicrobial bloodstream infections in hematologic malignancy patients: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-3527","authenticated-orcid":false,"given":"Nur O\u011fuz","family":"Davuto\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6590-6469","authenticated-orcid":false,"given":"G\u00f6khan","family":"Pekta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0055-7688","authenticated-orcid":false,"given":"Mehmet Bilgehan","family":"Pekta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"12660_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1086\/374339","volume":"36","author":"H Wisplinghoff","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the united States. Clin Infect Dis. 2003;36:1103\u201310.","journal-title":"Clin Infect Dis"},{"key":"12660_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s15010-011-0229-y","volume":"40","author":"M Mikulska","year":"2012","unstructured":"Mikulska M, et al. Mortality after bloodstream infections in allogeneic Haematopoietic stem cell transplant (HSCT) recipients. Infection. 2012;40:271\u20138.","journal-title":"Infection"},{"key":"12660_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1469-0691.2005.01298.x","volume":"12","author":"M N\u00f8rgaard","year":"2006","unstructured":"N\u00f8rgaard M, Larsson H, Pedersen G, Sch\u00f8nheyder HC, S\u00f8rensen HT. Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect. 2006;12:217\u201323.","journal-title":"Clin Microbiol Infect"},{"key":"12660_CR4","first-page":"2521","volume":"21","author":"G Samonis","year":"2013","unstructured":"Samonis G, et al. A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies. Support Care Cancer. 2013;21:2521\u20136.","journal-title":"Support Care Cancer"},{"key":"12660_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/23744235.2017.1347814","volume":"49","author":"A Kolonen","year":"2017","unstructured":"Kolonen A, et al. Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish leukemia group AML-2003 protocol \u2013 a prospective nationwide study. Infect Dis (Auckl). 2017;49:799\u2013808.","journal-title":"Infect Dis (Auckl)"},{"key":"12660_CR6","first-page":"6023","volume":"28","author":"JC Valentine","year":"2020","unstructured":"Valentine JC, et al. Burden and clinical outcomes of hospital-coded infections in patients with cancer: an 11-year longitudinal cohort study at an Australian cancer centre. Support Care Cancer. 2020;28:6023\u201334.","journal-title":"Support Care Cancer"},{"key":"12660_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s15010-019-01370-x","volume":"48","author":"Y Tang","year":"2020","unstructured":"Tang Y, Wu X, Cheng Q, Li X. Inappropriate initial antimicrobial therapy for hematological malignancies patients with Gram-negative bloodstream infections. Infection. 2020;48:109\u201316.","journal-title":"Infection"},{"key":"12660_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jgar.2013.06.005","volume":"1","author":"M Pavlaki","year":"2013","unstructured":"Pavlaki M, et al. Polymicrobial bloodstream infections: epidemiology and impact on mortality. J Glob Antimicrob Resist. 2013;1:207\u201312.","journal-title":"J Glob Antimicrob Resist"},{"key":"12660_CR9","doi-asserted-by":"publisher","first-page":"e0185768","DOI":"10.1371\/journal.pone.0185768","volume":"12","author":"C Royo-Cebrecos","year":"2017","unstructured":"Royo-Cebrecos C, et al. A fresh look at polymicrobial bloodstream infection in cancer patients. PLoS ONE. 2017;12:e0185768.","journal-title":"PLoS ONE"},{"key":"12660_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","volume":"19","author":"C Gudiol","year":"2013","unstructured":"Gudiol C, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013;19:474\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"12660_CR11","doi-asserted-by":"crossref","unstructured":"Moghnieh R, Kanafani ZA, Abi Hanna P. 2016 Lebanese society of infectious diseases and clinical microbiology guidelines on the management of febrile neutropenia in adult cancer patients in the era of growing antimicrobial resistance. Leban Med J. 2017;65:63\u201382.","DOI":"10.12816\/0038540"},{"key":"12660_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/QCO.0000000000000038","volume":"27","author":"EM Trecarichi","year":"2014","unstructured":"Trecarichi EM, Tumbarello M. Antimicrobial-resistant gram-negative bacteria in febrile neutropenic patients with cancer. Curr Opin Infect Dis. 2014;27:200\u201310.","journal-title":"Curr Opin Infect Dis"},{"key":"12660_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"12660_CR14","unstructured":"National Healthcare Safety Network (NHSN), U. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-Central Line Associated Bloodstream Infection). 2025."},{"key":"12660_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1089\/sur.2018.207","volume":"20","author":"Q Liu","year":"2019","unstructured":"Liu Q, et al. Polymicrobial bacteremia involving Klebsiella pneumoniae in patients with complicated intra-abdominal infections: frequency, co-pathogens, risk factors, and clinical outcomes. Surg Infect (Larchmt). 2019;20:317\u201325.","journal-title":"Surg Infect (Larchmt)"},{"key":"12660_CR16","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1553-2712.2010.00871.x","volume":"17","author":"J Lin","year":"2010","unstructured":"Lin J, et al. Characteristics and outcomes of polymicrobial bloodstream infections in the emergency department: a matched case\u2013control study. Acad Emerg Med. 2010;17:1072\u20139.","journal-title":"Acad Emerg Med"},{"key":"12660_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00134-020-05950-6","volume":"46","author":"J-F Timsit","year":"2020","unstructured":"Timsit J-F, Rupp\u00e9 E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46:266\u201384.","journal-title":"Intensive Care Med"},{"key":"12660_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2147\/IDR.S396428","volume":"16","author":"L Xu","year":"2023","unstructured":"Xu L, Meng H, Niu M, et al. Risk factors and prognosis of bloodstream infection with carbapenem-resistant Klebsiella pneumoniae in hematological malignancy patients. Infect Drug Resist. 2023;16:337\u201345. https:\/\/doi.org\/10.2147\/IDR.S396428.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"12660_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7150\/ijms.7.101","volume":"7","author":"T Kuwahara","year":"2010","unstructured":"Kuwahara T, Shimono K, Kaneda S, Tamura T, Ichihara M, Nakashima Y. Growth microorganisms in total parenteral nutrition solutions containing lipid. Int J Med Sci. 2010;7(3):101\u20139. https:\/\/doi.org\/10.7150\/ijms.7.101.","journal-title":"Int J Med Sci"},{"key":"12660_CR20","first-page":"2359","volume":"30","author":"G Facchin","year":"2022","unstructured":"Facchin G, et al. Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey. Support Care Cancer. 2022;30:2359\u201366.","journal-title":"Support Care Cancer"},{"key":"12660_CR21","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s10096-011-1503-8","volume":"31","author":"S Sancho","year":"2012","unstructured":"Sancho S, et al. Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients. Eur J Clin Microbiol Infect Dis. 2012;31:1791\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"12660_CR22","doi-asserted-by":"publisher","first-page":"e0227772","DOI":"10.1371\/journal.pone.0227772","volume":"15","author":"C Baier","year":"2020","unstructured":"Baier C, et al. Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients. PLoS ONE. 2020;15:e0227772.","journal-title":"PLoS ONE"},{"key":"12660_CR23","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.2147\/IDR.S412669","volume":"16","author":"J Xu","year":"2023","unstructured":"Xu J, et al. Microbiological analysis and mortality risk factors in patients with polymicrobial bloodstream infections. Infect Drug Resist. 2023;16:3917\u201327.","journal-title":"Infect Drug Resist"},{"key":"12660_CR24","doi-asserted-by":"publisher","first-page":"e2012028","DOI":"10.4084\/mjhid.2012.028","volume":"4","author":"A Abdollahi","year":"2012","unstructured":"Abdollahi A, Shoar S, Nayyeri F, Shariat M. Diagnostic value of simultaneous measurement of procalcitonin, interleukin-6 and hs-CRP in prediction of early-onset neonatal sepsis. Mediterr J Hematol Infect Dis. 2012;4:e2012028.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"12660_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2018.03.005","volume":"77","author":"JF McNamara","year":"2018","unstructured":"McNamara JF, et al. Long-term morbidity and mortality following bloodstream infection: a systematic literature review. J Infect. 2018;77:1\u20138.","journal-title":"J Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12660-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12660-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12660-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:14:14Z","timestamp":1770977654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12660-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12660"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12660-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed after approval was obtained from the local Ethics Committee of the Mu\u011fla S\u0131tk\u0131 Ko\u00e7man University (03.01.2025\u2013240235). Informed consent was obtained from all volunteers and\/or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"335"}}